XML 19 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
SHAREHOLDERS' EQUITY (Details) (USD $)
 0 Months Ended 3 Months Ended 1 Months Ended 0 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended 12 Months Ended
Jan. 22, 2013
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
As Reported
Mar. 31, 2012
As Reported
Mar. 31, 2013
Adjustment
Mar. 31, 2012
Adjustment
Mar. 31, 2013
Rights offering
item
Mar. 05, 2013
RCF
Short term financing
Mar. 31, 2013
RCF
Short term financing
Jan. 31, 2013
RCF
Short term financing
Mar. 31, 2013
RCF
Short term financing
Dec. 31, 2012
RCF
Short term financing
Mar. 31, 2013
RCF
Rights offering
Short term financing
Jan. 31, 2013
Cormark Securities, Inc.
Jan. 31, 2013
Neutron Energy, Inc.
Cormark Securities, Inc.
Mar. 31, 2013
Common Stock
Dec. 31, 2012
Common Stock
As Reported
Mar. 31, 2013
Paid-In Capital
Dec. 31, 2012
Paid-In Capital
As Reported
Mar. 31, 2013
Accumulated Deficit
Dec. 31, 2012
Accumulated Deficit
As Reported
Dec. 31, 2012
Accumulated Deficit
Adjustment
Mar. 31, 2013
Treasury Stock
Dec. 31, 2012
Treasury Stock
Dec. 31, 2012
Treasury Stock
As Reported
SHAREHOLDERS' EQUITY                                                    
Reverse stock split ratio 0.1                                                  
Common stock outstanding before reverse stock split (in shares) 161,100,000                                                  
Common stock, shares outstanding 16,150,163 19,821,681                             19,821,681 16,150,161                
Changes in shareholders equity                                                    
Balance at the beginning of the period (in shares)   16,150,161                             16,150,161 16,150,161                
Balance at the beginning of the period   $ 36,169,042                             $ 16,154 $ 16,154 $ 207,338,549 $ 207,338,549 $ (171,176,243) $ (162,201,908)   $ (9,418) $ (9,418) $ (9,418)
Prior period adjustments                                             (8,974,335)      
Net loss (as restated)   (4,473,447) (4,209,665) (4,150,592) (3,606,470) (322,855) (603,195)                           (4,473,447)          
Stock compensation expense                                     244,985              
Common stock issued - payment of loan principal and interest (in shares)                   26,482 4,861           1,992,127                  
Common stock issued - payment of loan principal and interest                                 1,992   5,093,841              
Common stock issued - shareholder rights offering (in shares)                                 1,547,843                  
Common stock issued - shareholder rights offering                                 1,548   3,632,335              
Common stock issued for services (in shares)                             83,200   83,200                  
Common stock issued for services   291,500                             83   291,417              
Restricted stock issuance (in shares)                                 48,350                  
Restricted stock issuance                                 48   (48)              
Balance at the end of the period (in shares) 16,150,163 19,821,681                             19,821,681 16,150,161                
Balance at the end of the period   40,961,796   50,258,986   (9,297,190)                     19,825 16,154 216,601,079 207,338,549 (175,649,690) (162,201,908)   (9,418) (9,418) (9,418)
Net proceeds from sale of shares of common stock in cash               3,600,000                                    
Short term financing repaid                           5,000,000                        
Number of shares of common stock issued upon conversion                 1,960,000         1,960,000                        
Interest accrued on the loan                       79,167 16,667                          
Number of subscription rights issued for each share of common stock owned or subject to a warrant               1                                    
Number of non-transferrable subscription rights received (in shares)               0.3119                                    
Exercise price (in dollars per share)               $ 2.55                                    
Fees related to acquisition                               $ 291,500